U.S. Considers Allowing Drug Licensing, Chinese Biopharma Stocks Rally
Hong Kong drug stocks jumped after a report the U.S. Treasury is drafting rules to let American firms license or invest in most Chinese drug programs.
Every Axis Signal story on this subject - 12 reports, filed under Business, Culture
Hong Kong drug stocks jumped after a report the U.S. Treasury is drafting rules to let American firms license or invest in most Chinese drug programs.
Fed’s Quarter-Point Hike Sends Dow Down 1.7%, Cramer Sees Quiet Week Ahead
The Fed’s quarter-point rate increase pushed the Dow down 1.7% for the week. Jim Cramer expects a light earnings slate led by Okta’s analyst meeting.
J.B. Hunt Stock Falls 10% After Company Warns Q3 Earnings Will Drop
Shares tumbled after J.B. Hunt said Q3 earnings will fall 5% to 10% as recruiting, onboarding and record diesel prices squeeze margins.
Larry Ellison Cancels Plan To Sell Up To $7.5 Billion Of Oracle Stock
Ellison scrapped a 10b5-1 plan to sell up to 50 million Oracle shares, worth $7.5 billion. No shares were sold and he has no other sale plans.
Surging Oil and Yields Push Stocks Lower, Meta and Apple Offer AI Upside
Rising crude and 10-year yields drove weekly losses for major indices, while Meta and Apple’s AI moves reinforced longer-term investment cases.
Rising Stocks and Falling Bonds Leave Portfolios Riskier, Advisers Urge Rebalancing
Stocks are near highs while long-term bond funds have fallen; advisers say rebalancing to target allocations reduces unintended equity exposure.
Portfolio Cuts AI Winners and Adds Defensive Stocks as Yields Rise
Rising oil and Treasury yields prompted a shift from AI leaders to defensive stocks. The portfolio locked gains in Palo Alto and Corning and added
Tesla Cybercab Launch Lifts Shares, Trader Funds December Calls With Short Strangle
Cybercab hype pushed Tesla higher and opened a short-term options trade. Khouw buys December 390 calls and finances them by selling an Oct 23 425/330
Berkshire Hathaway Profit Rises 16% as Greg Abel Accelerates Buybacks and Investments
Berkshire Hathaway reported a 16% increase in second-quarter operating earnings as stronger performances across its energy, railroad and manufacturing businesses offset weaker insurance results, while CEO Greg Abel stepped up capital deployment.
Novo Nordisk Shares Drop After Ziltivekimab Fails To Cut Major Heart Events
Shareholders reacted as Novo Nordisk’s experimental drug ziltivekimab failed to produce a statistically meaningful reduction in major cardiovascular
Microsoft Gains 15% While Meta Falls 8% After AI Revenue Split and Cash‑Flow Miss
Microsoft climbed 15% on Azure and Copilot momentum. Meta sank 8% after missing revenue guidance and a plunge in free cash flow.
Investors Lose As SK Hynix And Samsung Shares Plunge On AI Demand Fears
Sharp falls in SK Hynix and Samsung have wiped recent gains, stoking doubts about AI spending, chip supply and valuations.